Obtaining and characterization of a recombinant LipL32 protein for detection of leptospirosis

A Zhylkibayev1, Z Akishev1, B Khassenov1

  • 1National Center for Biotechnology, 13/5 Korgalzhyn Road, Astana, Kazakhstan, 010000.

Tropical Biomedicine
|February 19, 2021
PubMed

Insights

This study produced a recombinant LipL32 protein for leptospirosis detection. The protein showed high reactivity, indicating its potential for developing new diagnostic tools for leptospirosis.

Area of Science:

  • Microbiology
  • Immunology
  • Veterinary Medicine

Background:

  • Leptospirosis is a zoonotic disease affecting humans and animals.
  • The LipL32 outer membrane lipoprotein is a key antigen for leptospirosis diagnosis.

Purpose of the Study:

  • To produce and characterize recombinant LipL32 protein.
  • To evaluate the diagnostic performance of recombinant LipL32 in an in-house ELISA.

Main Methods:

  • LipL32 gene optimization and expression in Escherichia coli (Rosetta (DE3) strain).
  • Protein solubilization using sodium lauryl sulfate and isolation from inclusion bodies.
  • Immunochemical characterization and development of an indirect ELISA.

Main Results:

  • Recombinant LipL32 protein was successfully produced and purified.
  • The recombinant protein demonstrated high reactivity with antibodies from pathogenic Leptospira infections.
  • The in-house ELISA showed comparable specificity to the traditional microagglutination test (MAT).

Conclusions:

  • Recombinant LipL32 is a promising antigen for leptospirosis diagnosis.
  • The developed in-house ELISA using recombinant LipL32 is a viable diagnostic tool.

Related Concept Videos